TNFRSF1B and rheumatoid arthritis: Blood samples from RA patients with TNFRSF1B:rs3397 (CT or TT genotype) were significantly positive for MAP DNA (38.1% and 66.6%, respectively), compared to blood from RA patients with the wildtype (CC) genotype (16.7%, p-value < 0.05).